Tetraphase Pharmaceuticals, Inc. today announced that the underwriters for its initial public offering have exercised their over-allotment option and purchased an additional 797,792 shares in the offering.
http://www.businesswire.com/news/topix/20130412005636/en
http://www.businesswire.com/news/topix/20130412005636/en
No comments:
Post a Comment